This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

 Previous Article  |  Next Article 

Liquid topical skin `glue,' effective as suturees in testing, wins FDA approval

The Food and Drug Administration (FDA) has approved for marketing a liquid, topical skin adhesive or "glue," said to be a faster, less painful method of wound closure than sutures.

Dermabond Topical Skin Adhesive (Octyl 2 Cyanoacrylate) from Ethicon, Inc., is recommended for closure of easily approximated skin edges of wounds from surgical incisions, including punctures from minimally invasive surgery and simple, thoroughly cleansed trauma-induced lacerations. The adhesive should be used in conjunction with, but not in place of, subcuticular sutures when required. In many cases, Dermabond adhesive can eliminate the need for an anesthetic injection in wound closure.